Research ArticleOncology
18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
Gabriele D. Maurer, Daniel P. Brucker, Gabriele Stoffels, Katharina Filipski, Christian P. Filss, Felix M. Mottaghy, Norbert Galldiks, Joachim P. Steinbach, Elke Hattingen and Karl-Josef Langen
Journal of Nuclear Medicine April 2020, 61 (4) 505-511; DOI: https://doi.org/10.2967/jnumed.119.234757
Gabriele D. Maurer
1Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt am Main, Germany
2University Cancer Center Frankfurt, Goethe University Hospital, Frankfurt am Main, Germany
3German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Heidelberg, Germany
Daniel P. Brucker
2University Cancer Center Frankfurt, Goethe University Hospital, Frankfurt am Main, Germany
3German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Heidelberg, Germany
Gabriele Stoffels
4Institute of Neuroscience and Medicine (INM-3 and INM-4), Research Center Juelich, Juelich, Germany
Katharina Filipski
3German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Heidelberg, Germany
5German Cancer Research Center (DKFZ), Heidelberg, Germany
6Institute of Neurology (Edinger Institute), Goethe University Hospital, Frankfurt am Main, Germany
Christian P. Filss
4Institute of Neuroscience and Medicine (INM-3 and INM-4), Research Center Juelich, Juelich, Germany
7Department of Nuclear Medicine, RWTH University Hospital, Aachen, Germany
Felix M. Mottaghy
7Department of Nuclear Medicine, RWTH University Hospital, Aachen, Germany
8Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
9Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany
Norbert Galldiks
4Institute of Neuroscience and Medicine (INM-3 and INM-4), Research Center Juelich, Juelich, Germany
9Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany
10Department of Neurology, University Hospital Cologne, Cologne, Germany; and
Joachim P. Steinbach
1Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt am Main, Germany
2University Cancer Center Frankfurt, Goethe University Hospital, Frankfurt am Main, Germany
3German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Heidelberg, Germany
Elke Hattingen
11Institute of Neuroradiology, Goethe University Hospital, Frankfurt am Main, Germany
Karl-Josef Langen
4Institute of Neuroscience and Medicine (INM-3 and INM-4), Research Center Juelich, Juelich, Germany
7Department of Nuclear Medicine, RWTH University Hospital, Aachen, Germany
9Center of Integrated Oncology, Universities of Aachen, Bonn, Cologne, and Duesseldorf, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
Gabriele D. Maurer, Daniel P. Brucker, Gabriele Stoffels, Katharina Filipski, Christian P. Filss, Felix M. Mottaghy, Norbert Galldiks, Joachim P. Steinbach, Elke Hattingen, Karl-Josef Langen
Journal of Nuclear Medicine Apr 2020, 61 (4) 505-511; DOI: 10.2967/jnumed.119.234757
18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
Gabriele D. Maurer, Daniel P. Brucker, Gabriele Stoffels, Katharina Filipski, Christian P. Filss, Felix M. Mottaghy, Norbert Galldiks, Joachim P. Steinbach, Elke Hattingen, Karl-Josef Langen
Journal of Nuclear Medicine Apr 2020, 61 (4) 505-511; DOI: 10.2967/jnumed.119.234757